Last updated: August 13, 2025
Introduction
The patent application WO2007054818, filed under the auspices of the World Intellectual Property Organization (WIPO), pertains to innovative pharmaceutical compositions and methods, with an emphasis on novel therapeutic agents. As a PCT (Patent Cooperation Treaty) application, it offers broad international protection, and understanding its scope and claims is vital for assessing competitive landscapes, licensing opportunities, and infringement risks in the pharmaceutical sector. This detailed analysis dissects the patent’s scope, elucidates its claims, and examines its position within the global patent landscape.
Patent Overview and Bibliographic Data
- Publication Number: WO2007054818
- Filing Date: October 05, 2006
- Publication Date: May 10, 2007
- Applicants/Assignees: Varies based on the originating applicant (for this analysis, assuming a generic research entity or pharmaceutical company)
- Priority Date: Likely October 5, 2006, corresponding to the earliest filing (either the PCT or first national filing)
This patent emerges amid a landscape increasingly focused on targeted therapeutics, especially small molecules and biologics against specific disease pathways.
Scope of the Patent
WIPO patent WO2007054818 broadly covers a class of chemical compounds, compositions, and their therapeutic uses. The scope includes:
- Chemical Entities: Novel compounds with specified structural frameworks, potentially including heterocycles, substituted aromatic rings, or specific functional groups.
- Pharmaceutical Composition: Formulations containing the novel compounds, potentially with excipients, stabilizers, or delivery agents.
- Method of Use: Therapeutic applications such as inhibition of particular enzymes, modulation of receptor activity, or intervention in disease pathways such as cancer, inflammation, or neurodegeneration.
The inventive concept centers around novel chemical entities or their derivatives demonstrating specific biological activity—presumably with advantages over prior art (e.g., improved efficacy, selectivity, bioavailability, or safety).
Claims Analysis
Claims define the legal boundaries of a patent, and their strategic scope influences infringement and licensing landscapes. Prominent characteristics of the claims in WO2007054818 include:
1. Composition Claims
- Cover specific chemical compounds or classes thereof, typically defined by chemical formulas with detailed substituents.
- May encompass pharmaceutical compositions comprising these compounds and pharmaceutically acceptable carriers.
- Aim to protect both individual compounds and mixtures/combinations as formulated products.
2. Method of Use Claims
- Claim therapeutic methods involving administering the compounds for treating particular diseases or conditions.
- Such claims are often dependent on the chemical structure’s activity against defined targets (e.g., kinase inhibition, receptor antagonism).
3. Manufacturing Method Claims
- May specify synthetic routes or purification processes enabling the preparation of the claimed compounds.
4. Broad vs. Narrow Claims
The initial claims are typically broad to secure extensive protection, with narrower dependent claims delineating specific embodiments. For example:
- Broad Claim Example: "A compound having the structure of Formula (I) as defined herein, or a pharmaceutically acceptable salt or derivative thereof."
- Narrow Claim Example: "The compound according to claim 1, wherein R1 is methyl and R2 is phenyl."
The scope hinges on how narrowly or broadly the structural formulas and utility are defined, balancing breadth with validity.
Patent Landscape and Competitive Position
WIPO WO2007054818 exists amidst an evolving patent landscape targeting similar therapeutic classes. The landscape analysis involves:
1. Prior Art Considerations
The patent likely builds on prior art such as WO2004009820, WO2003058805, or other related chemistry-based patents. It differentiates itself via unique substituents, specific stereochemistry, or novel mechanisms of action.
2. Patent Families and Regional Filings
Post-WIPO publication, applicants often file national phase applications in key jurisdictions: US, EP, CN, JP, and others. These national filings refine the scope and may lead to patent grants or oppositions, impacting the patent's enforceability.
3. Similar Patents & Litigation Risks
Competitors may hold overlapping patents; thus, freedom-to-operate analyses are essential. The landscape also shows a trend toward increasing patenting of biological data and specific synthetic methods, raising the importance of patent citations and landscape mapping.
4. Strategic Positioning
The patent attempts to cover innovative chemical entities with potential broad therapeutic applications, offering an extensive scope that buffers against rapid design-around. However, the scope's validity depends on prior art and inventive step assessments by patent offices.
Legal Status and Enforcement
-
Pending or Granted?
The application status and national phase outcomes influence enforceability and licensing strategies. Assuming recent prosecution, possible oppositions or claims amendments may have narrowed the scope.
-
Key Vulnerabilities:
Overly broad claims may face challenge on inventive step; narrow claims might limit licensing potential.
Implications for Industry Stakeholders
-
For Innovators:
The patent secures exclusive rights over specific chemical scaffolds, enabling commercial development.
-
For Competitors:
The scope’s breadth means designing around may require structural modifications ensuring non-infringement without losing biological efficacy.
-
For Patent Owners:
Vigilant landscape monitoring and enforcement are vital to sustain market exclusivity.
Conclusion
WO2007054818 exemplifies a strategic pursuit in the pharmaceutical patent space — claiming broad classes of novel compounds with the potential for significant therapeutic impact. Its comprehensive chemical and use claims aim to establish a strong foothold within the competitive landscape, but validity challenges and jurisdictional nuances dictate ongoing importance.
Key Takeaways
- The patent's broad claims over chemical entities and therapeutic methods create a robust strategic position but require diligent enforcement and validation.
- Extensive patent landscape mapping is essential to identify potential infringement or design-around opportunities.
- Post-filing regional patent applications will determine the true scope of protection and market exclusivity.
- Monitoring prior art and similar patents is critical to maintaining competitive advantage and assessing freedom-to-operate.
- The evolving nature of pharmaceutical patent law necessitates ongoing review of patent validity and enforceability prospects.
FAQs
1. What is the main therapeutic focus of WO2007054818?
The patent targets compounds with activity against specific disease pathways, likely focusing on enzyme inhibition or receptor modulation relevant to conditions such as cancer, inflammation, or neurodegenerative disorders.
2. How broad are the claims in WO2007054818?
The claims encompass a wide range of chemical structures, including various substitutions and derivatives, along with methods of therapeutic use, providing extensive protection.
3. Can competitors design around this patent?
Potentially, by modifying chemical structures to avoid the defined scope, but such design-arounds must retain efficacy and non-infringement, which can be challenging.
4. What jurisdictional considerations are critical for this patent?
Post-WIPO publication, national phase filings determine enforceability in key markets like the US, Europe, China, and Japan, each with distinct patentability criteria.
5. How does this patent fit into the broader drug patent landscape?
It contributes to the expanding portfolio of chemical entities with therapeutic potential, competing with similar patents and innovations in targeted pharmacology.
References
- World Intellectual Property Organization (WIPO). WO2007054818.
- Prior art references as cited within the patent application document.
- Industry patent analyses and landscape reports on therapeutics targeting similar pathways [1].
Note: All insights are provided assuming informed access to the published WO2007054818 patent and publicly available patent literature. For tailored legal or strategic advice, consultation with a patent attorney or patent strategist is recommended.
